Investment
Features
FeesSafety
Academy
More
Pluang+

Award-winning Assange film bypasses streamers with Bitcoin-only pay-per-view event

Market News
24 Jun 2026
Crypto Briefing
View Source
Bullish
Award-winning Assange film bypasses streamers with Bitcoin-only pay-per-view event

Eugene Jarecki, director of the acclaimed documentary The Six Billion Dollar Man about Julian Assange, partnered with Jack Dorsey to release the film via a Bitcoin-only pay-per-view screening after major streaming platforms refused to carry it. The event, set for June 27, 2026, requires viewers to pay 0.01 BTC (around $760) to watch and join a post-film panel featuring Edward Snowden. This approach highlights Bitcoin's role as a censorship-resistant payment method, echoing its early use by WikiLeaks when traditional payment systems blocked donations. The initiative positions viewers as "Bitcoin Producers," emphasizing a new model of content distribution tied to Bitcoin's anti-censorship ethos.

More News

AAVE token jumps over 10% in 24 hours, hitting $163 amid $140K short liquidations.

AAVE token jumps over 10% in 24 hours, hitting $163 amid $140K short liquidations.

The cryptocurrency AAVE surged 9.31% within four hours to reach $163, extending its 24-hour gain to 10.07%. This price increase was accompanied by $140,000 in short liquidations on major exchanges like Binance, Bybit, and OKX, while no long liquidati...

Market News
Bullish
4 hours ago
Bitcoin, Ethereum, Solana, and XRP spot ETFs see $65M inflows on Sept 28, signaling broad institutional interest.

Bitcoin, Ethereum, Solana, and XRP spot ETFs see $65M inflows on Sept 28, signaling broad institutional interest.

On September 28, all four major crypto spot ETFs—Bitcoin, Ethereum, Solana, and XRP—recorded net inflows totaling about $65 million, highlighting growing institutional demand beyond Bitcoin alone. Bitcoin ETFs led with $31.07 million, followed by Eth...

Market News
Bullish
4 hours ago
Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.

Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.

Poolbeg Pharma has secured funding to complete its clinical trials through to the second quarter of 2028. The company is currently recruiting patients for its TOPICAL trial of POLB 001, a drug aimed at preventing cytokine release syndrome in cancer p...

Market News
Bullish
4 hours ago
Genflow Biosciences to reveal dog longevity trial results and advance glaucoma and liver disease programs

Genflow Biosciences to reveal dog longevity trial results and advance glaucoma and liver disease programs

Genflow Biosciences will present full results from its canine ageing trial at the Animal Longevity Summit in Toronto, highlighting the safety and potential health benefits of its GF-1004 treatment aimed at slowing ageing. The company is also progress...

Market News
Bullish
4 hours ago
Bitcoin dips below $83K, wiping out $500M in leveraged crypto bets amid oil and gold market shocks

Bitcoin dips below $83K, wiping out $500M in leveraged crypto bets amid oil and gold market shocks

Bitcoin's price fell below $83,000 on September 28-29, triggering the liquidation of about $500 million in leveraged crypto positions and impacting 129,197 traders. The drop was influenced by rising oil prices after geopolitical tensions and a rare 3...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App